Obalon Therapeutics (NASDAQ: OBLN): Q3 2019 Earnings Snapshot
Obalon Therapeutics (NASDAQ: OBLN): Q3 2019 Earnings Snapshot
— Obalon Therapeutics (NASDAQ: OBLN) reported a net loss of $0.61 per share for the third quarter of 2019, vs. $2.14 per share expected
— Third-quarter net loss was $3.7 million, compared to a loss of $6.7 million a year earlier
— Revenue decreased to $0.3 million from $3.0 million for the third quarter of 2018, vs. $1.2 million expected
— Cost of revenue was $0.4 million, down…
View On WordPress









